D
Duly Health and Care | 2614 W. Jefferson Street
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Estrogen
Trilaciclib
Lurbinectedin
Topotecan
Sacituzumab
Everolimus
Irinotecan
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 3 total trials
Locations recently updated
This Phase III, randomized, open-label, multicenter study will evaluate the efficacy and safety of giredestrant plus everolimus compared with the phy...
Enrolling
Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer
Drug: Fulvestrant
Drug: Dexamethasone Mouth Rinse
Multicenter, open-label, randomized, controlled phase III clinical trial to evaluate and compare the activity and safety of two experimental arms con...
Enrolling
Relapsed Small Cell Lung Cancer
Drug: Irinotecan
Drug: Lurbinectedin
This is a Phase 2, multicenter, open-label, single arm study evaluating the safety and efficacy of trilaciclib administered prior to sacituzumab govi...
Active, not recruiting
Triple Negative Breast Cancer
Drug: Sacituzumab Govitecan-hziy
Drug: Trilaciclib
Trial sponsors
G
P
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems